Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES

Filed by SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 22, 2026
Income
Not reported
Expenses
$50,000.00
Filing UUID
41e3f54c-d966-4902-95ed-7cfaa079e2ac
Termination date
Not reported

Expense method: C

Literal source text

Lobbying issues and bill citations

CHM · Chemicals/Chemical Industry

Issues related to the Toxic Substances Control Act and draft legislative proposals in the House and Senate. Issues related to the Environmental Protection Agencys New Chemicals Program. Issues related to the Environmental Protection Agencys Risk Management Program (RMP). Issues related to the Environmental Protection Agencys Integrated Risk Information System (IRIS). Issues related to tariffs, international trade, and the competitiveness of U.S. chemical manufacturing. Issues related to reshoring and domestic manufacturing policies affecting the specialty chemical industry. Issues related to supply chain resilience, domestic production capacity, and availability of critical chemical inputs.

MAN · Manufacturing

Issues related to the Environmental Protection Agencys New Chemicals Program. Issues related to reshoring and domestic manufacturing policies affecting the specialty chemical industry.

TRD · Trade (domestic/foreign)

Issues related to tariffs, international trade, and the competitiveness of U.S. chemical manufacturing. Issues related to reshoring and domestic manufacturing policies affecting the specialty chemical industry.

AVI · Aviation/Airlines/Airports

Issues related to the Federal Aviation Administration's proposed rule restricting unmanned aircraft systems (UAS) operations over certain fixed-site facilities, including chemical facilities.

PHA · Pharmacy

Issues related to pharmaceutical supply chain resilience, domestic manufacturing of pharmaceuticals and critical chemical inputs, and reducing reliance on foreign sources.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.